在服务不足的社区传播艾滋病病毒暴露前预防信息。 - Suppr

Suppr

超能文献

Disseminating HIV pre-exposure prophylaxis information in underserved communities.

作者信息

Dutta Mohan J

机构信息

Center for Culture-Centered Approach to Research and Evaluation (CARE), National University of Singapore, Singapore.

出版信息

Am J Prev Med. 2013 Jan;44(1 Suppl 2):S133-6. doi: 10.1016/j.amepre.2012.09.030.

DOI:10.1016/j.amepre.2012.09.030

PMID:23253754

Abstract

摘要

相似文献

Disseminating HIV pre-exposure prophylaxis information in underserved communities.

Am J Prev Med. 2013 Jan;44(1 Suppl 2):S133-6. doi: 10.1016/j.amepre.2012.09.030.

Providing HIV pre-exposure prophylaxis: lessons learned from the Ryan White HIV/AIDS Program.

Am J Prev Med. 2013 Jan;44(1 Suppl 2):S147-50. doi: 10.1016/j.amepre.2012.09.031.

HIV pre-exposure prophylaxis diffusion and implementation issues in nonclinical settings.

Am J Prev Med. 2013 Jan;44(1 Suppl 2):S129-32. doi: 10.1016/j.amepre.2012.09.032.

Introducing wicked issues for HIV pre-exposure prophylaxis implementation in the U.S.

Am J Prev Med. 2013 Jan;44(1 Suppl 2):S59-62. doi: 10.1016/j.amepre.2012.09.057.

Primary care and public health partnerships for implementing pre-exposure prophylaxis.

Am J Prev Med. 2013 Jan;44(1 Suppl 2):S77-9. doi: 10.1016/j.amepre.2012.09.037.

Social justice, public health ethics, and the use of HIV pre-exposure prophylaxis.

Am J Prev Med. 2013 Jan;44(1 Suppl 2):S137-40. doi: 10.1016/j.amepre.2012.09.029.

Pre-exposure prophylaxis for HIV: who will benefit and what are the challenges?

Am J Prev Med. 2013 Jan;44(1 Suppl 2):S163-6. doi: 10.1016/j.amepre.2012.10.005.

Pre-exposure prophylaxis for HIV: can it be implemented in the real world?

Am J Prev Med. 2013 Jan;44(1 Suppl 2):S161-2. doi: 10.1016/j.amepre.2012.10.004.

From efficacy to impact: an advocate's agenda for HIV pre-exposure prophylaxis implementation.

Am J Prev Med. 2013 Jan;44(1 Suppl 2):S167-70. doi: 10.1016/j.amepre.2012.10.006.

Next steps in designing for diffusion of pre-exposure prophylaxis: demonstration projects.

Am J Prev Med. 2013 Jan;44(1 Suppl 2):S156-60. doi: 10.1016/j.amepre.2012.09.028.

引用本文的文献

The use of oral HIV pre-exposure prophylaxis among people who inject drugs: barriers, and recommendations.

Front Public Health. 2023 Sep 5;11:1265063. doi: 10.3389/fpubh.2023.1265063. eCollection 2023.

A Multi-US City Assessment of Awareness and Uptake of Pre-exposure Prophylaxis (PrEP) for HIV Prevention Among Black Men and Transgender Women Who Have Sex with Men.

Prev Sci. 2017 Jul;18(5):505-516. doi: 10.1007/s11121-017-0756-6.

Acceptability of HIV Pre-exposure Prophylaxis (PREP) Among People Who Inject Drugs (PWID) in a Canadian Setting.

AIDS Behav. 2015 May;19(5):752-7. doi: 10.1007/s10461-014-0867-z.

HIV pre-exposure prophylaxis for people who inject drugs: a review of current results and an agenda for future research.

J Int AIDS Soc. 2014 Mar 27;17(1):18899. doi: 10.7448/IAS.17.1.18899. eCollection 2014.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Disseminating HIV pre-exposure prophylaxis information in underserved communities.

作者信息

Dutta Mohan J

机构信息

Center for Culture-Centered Approach to Research and Evaluation (CARE), National University of Singapore, Singapore.

出版信息

Am J Prev Med. 2013 Jan;44(1 Suppl 2):S133-6. doi: 10.1016/j.amepre.2012.09.030.

DOI:10.1016/j.amepre.2012.09.030

PMID:23253754

Abstract

摘要

相似文献

Disseminating HIV pre-exposure prophylaxis information in underserved communities.

Am J Prev Med. 2013 Jan;44(1 Suppl 2):S133-6. doi: 10.1016/j.amepre.2012.09.030.

Providing HIV pre-exposure prophylaxis: lessons learned from the Ryan White HIV/AIDS Program.

Am J Prev Med. 2013 Jan;44(1 Suppl 2):S147-50. doi: 10.1016/j.amepre.2012.09.031.

HIV pre-exposure prophylaxis diffusion and implementation issues in nonclinical settings.

Am J Prev Med. 2013 Jan;44(1 Suppl 2):S129-32. doi: 10.1016/j.amepre.2012.09.032.

Introducing wicked issues for HIV pre-exposure prophylaxis implementation in the U.S.

Am J Prev Med. 2013 Jan;44(1 Suppl 2):S59-62. doi: 10.1016/j.amepre.2012.09.057.

Primary care and public health partnerships for implementing pre-exposure prophylaxis.

Am J Prev Med. 2013 Jan;44(1 Suppl 2):S77-9. doi: 10.1016/j.amepre.2012.09.037.

Social justice, public health ethics, and the use of HIV pre-exposure prophylaxis.

Am J Prev Med. 2013 Jan;44(1 Suppl 2):S137-40. doi: 10.1016/j.amepre.2012.09.029.

Pre-exposure prophylaxis for HIV: who will benefit and what are the challenges?

Am J Prev Med. 2013 Jan;44(1 Suppl 2):S163-6. doi: 10.1016/j.amepre.2012.10.005.

Pre-exposure prophylaxis for HIV: can it be implemented in the real world?

Am J Prev Med. 2013 Jan;44(1 Suppl 2):S161-2. doi: 10.1016/j.amepre.2012.10.004.

From efficacy to impact: an advocate's agenda for HIV pre-exposure prophylaxis implementation.

Am J Prev Med. 2013 Jan;44(1 Suppl 2):S167-70. doi: 10.1016/j.amepre.2012.10.006.

Next steps in designing for diffusion of pre-exposure prophylaxis: demonstration projects.

Am J Prev Med. 2013 Jan;44(1 Suppl 2):S156-60. doi: 10.1016/j.amepre.2012.09.028.

引用本文的文献

The use of oral HIV pre-exposure prophylaxis among people who inject drugs: barriers, and recommendations.

Front Public Health. 2023 Sep 5;11:1265063. doi: 10.3389/fpubh.2023.1265063. eCollection 2023.

A Multi-US City Assessment of Awareness and Uptake of Pre-exposure Prophylaxis (PrEP) for HIV Prevention Among Black Men and Transgender Women Who Have Sex with Men.

Prev Sci. 2017 Jul;18(5):505-516. doi: 10.1007/s11121-017-0756-6.

Acceptability of HIV Pre-exposure Prophylaxis (PREP) Among People Who Inject Drugs (PWID) in a Canadian Setting.

AIDS Behav. 2015 May;19(5):752-7. doi: 10.1007/s10461-014-0867-z.

HIV pre-exposure prophylaxis for people who inject drugs: a review of current results and an agenda for future research.

J Int AIDS Soc. 2014 Mar 27;17(1):18899. doi: 10.7448/IAS.17.1.18899. eCollection 2014.